Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Christiane Thienelt

Concepts (64)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
2
2009
1573
0.140
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
1046
0.140
Why?
Lung Neoplasms
1
2005
2329
0.100
Why?
Agranulocytosis
1
2010
32
0.090
Why?
Levamisole
1
2010
21
0.090
Why?
Heparin
1
2011
240
0.080
Why?
BRCA2 Protein
1
2009
53
0.080
Why?
Thrombophilia
1
2009
66
0.080
Why?
Pregnancy Complications, Neoplastic
1
2009
52
0.080
Why?
Cocaine
1
2010
151
0.070
Why?
Venous Thromboembolism
1
2011
275
0.070
Why?
Anticoagulants
1
2011
614
0.070
Why?
Carboplatin
1
2005
140
0.060
Why?
Cetuximab
1
2005
94
0.060
Why?
Exanthema
1
2005
73
0.060
Why?
Area Under Curve
1
2005
282
0.060
Why?
Paclitaxel
1
2005
215
0.060
Why?
Fatigue
1
2005
320
0.050
Why?
Survival Analysis
1
2005
1265
0.050
Why?
ErbB Receptors
1
2005
603
0.050
Why?
Neoplasm Staging
1
2005
1293
0.050
Why?
Immunohistochemistry
1
2005
1671
0.050
Why?
Dose-Response Relationship, Drug
1
2005
1945
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2005
764
0.040
Why?
Antibodies, Monoclonal
1
2005
1359
0.040
Why?
Breast Neoplasms
1
2009
2150
0.030
Why?
Follow-Up Studies
1
2005
4915
0.030
Why?
Time Factors
1
2005
6518
0.030
Why?
Intermittent Pneumatic Compression Devices
1
2011
4
0.020
Why?
Treatment Outcome
1
2005
10226
0.020
Why?
Organizational Case Studies
1
2011
75
0.020
Why?
Personnel, Hospital
1
2011
26
0.020
Why?
Reimbursement, Incentive
1
2011
36
0.020
Why?
Staff Development
1
2011
57
0.020
Why?
Crack Cocaine
1
2010
8
0.020
Why?
Leukopenia
1
2010
28
0.020
Why?
Adult
3
2010
35512
0.020
Why?
Drug Contamination
1
2010
54
0.020
Why?
Organizational Innovation
1
2011
140
0.020
Why?
Neutropenia
1
2010
136
0.020
Why?
Leukocyte Count
1
2010
328
0.020
Why?
Pregnancy Trimester, Second
1
2009
79
0.020
Why?
Mastectomy, Segmental
1
2009
85
0.020
Why?
Cyclophosphamide
1
2009
232
0.020
Why?
Pregnancy Trimester, First
1
2009
138
0.020
Why?
Bone Marrow
1
2010
268
0.020
Why?
Apoptosis Regulatory Proteins
1
2009
182
0.020
Why?
Lymph Node Excision
1
2009
165
0.020
Why?
Cost-Benefit Analysis
1
2011
582
0.020
Why?
Doxorubicin
1
2009
322
0.020
Why?
Male
3
2010
63201
0.020
Why?
Aged
1
2005
22089
0.020
Why?
Middle Aged
1
2005
31079
0.010
Why?
Humans
4
2011
129126
0.010
Why?
Practice Guidelines as Topic
1
2011
1493
0.010
Why?
Quality Improvement
1
2011
1099
0.010
Why?
Female
2
2009
68517
0.010
Why?
Risk Assessment
1
2011
3260
0.010
Why?
Prognosis
1
2009
3788
0.010
Why?
Colorado
1
2011
4396
0.010
Why?
Postoperative Complications
1
2011
2496
0.010
Why?
Infant, Newborn
1
2009
5739
0.010
Why?
Pregnancy
1
2009
6375
0.010
Why?
United States
1
2011
13939
0.010
Why?
Thienelt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)